Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v48-FR Version v40-FR
Language French French
Date Updated 2021-11-23 2018-10-03
Drug Identification Number 02413493 02413493
Brand name MYLAN-RISPERIDONE ODT MYLAN-RISPERIDONE ODT
Common or Proper name RISPERIDONE ODT RISPERIDONE ODT
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients RISPERIDONE RISPERIDONE
Strength(s) 1MG 1MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 100BT 100BT
ATC code N05AX N05AX
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2017-01-23 2017-01-23
Estimated end date Unknown 2019-04-05
Actual end date 2021-11-15
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments